All Pharma News
Neurogene to Participate in Upcoming Conferences

Neurogene to Participate in Upcoming Conferences
BUSINESSWIRE
05 Jun 2024
Share Share
FDA picks Denali, Neurogene and more for rare disease program

FDA picks Denali, Neurogene and more for rare disease program
Helen Floersh FIERCE BIOTECH
04 Jun 2024
Share Share
Neurogene`s NGN-401 Rett Syndrome Gene Therapy In FDA START Program

Neurogene`s NGN-401 Rett Syndrome Gene Therapy In FDA START Program
BUSINESSWIRE
03 Jun 2024
Share Share
Neurogene Q1 2024 Financials, Recent Updates

Neurogene Q1 2024 Financials, Recent Updates
BUSINESSWIRE
10 May 2024
Share Share
Neurogene Rett Data At ASGCT Annual Meeting

Neurogene Rett Data At ASGCT Annual Meeting
BUSINESSWIRE
07 May 2024
Share Share
Neurogene Presenting NGN-401 Rett Syndrome Gene Therapy Safety Data

Neurogene Presenting NGN-401 Rett Syndrome Gene Therapy Safety Data
BUSINESSWIRE
22 Apr 2024
Share Share
Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results

Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results
BUSINESSWIRE
18 Mar 2024
Share Share
Neurogene Announces Expansion for Enrollment of Rett Syndrome Gene Therapy Trial

Neurogene Announces Expansion for Enrollment of Rett Syndrome Gene Therapy Trial
BUSINESSWIRE
04 Mar 2024
Share Share
Neurogene Announces Appointment of Julie Jordan, M.D., as Chief Medical Officer

Neurogene Announces Appointment of Julie Jordan, M.D., as Chief Medical Officer
BUSINESSWIRE
16 Jan 2024
Share Share
Neurogene Announces Business Update and 2024 Outlook

Neurogene Announces Business Update and 2024 Outlook
BUSINESSWIRE
05 Jan 2024
Share Share